The Discounted Cash Flow (DCF) valuation of Inhibrx Inc (INBX) is 1,035.97 USD. With the latest stock price at 69.71 USD, the upside of Inhibrx Inc based on DCF is 1386.1%.
Based on the latest price of 69.71 USD and our DCF valuation, Inhibrx Inc (INBX) is a buy. buying INBX stocks now will result in a potential gain of 1386.1%.
| Range | Selected | |
| WACC / Discount Rate | 7.6% - 11.9% | 9.8% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 821.97 - 1,421.15 | 1,035.97 |
| Upside | 1079.1% - 1938.7% | 1386.1% |